KARAOĞLAN, B. B. Et Al. 2025. Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis. JOURNAL OF GASTROINTESTINAL CANCER , vol.56, no.1 .

KARAOĞLAN, B. B., Ozturk, I., AKYOL, C., SAVAŞ, B., & UTKAN, G., (2025). Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis. JOURNAL OF GASTROINTESTINAL CANCER , vol.56, no.1.

KARAOĞLAN, BELİZ Et Al. "Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis," JOURNAL OF GASTROINTESTINAL CANCER , vol.56, no.1, 2025

KARAOĞLAN, BELİZ B. Et Al. "Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis." JOURNAL OF GASTROINTESTINAL CANCER , vol.56, no.1, 2025

KARAOĞLAN, B. B. Et Al. (2025) . "Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis." JOURNAL OF GASTROINTESTINAL CANCER , vol.56, no.1.

@article{article, author={BELİZ BAHAR KARAOĞLAN Et Al. }, title={Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis}, journal={JOURNAL OF GASTROINTESTINAL CANCER}, year=2025}